We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
- Authors
Munster, Pamela N; Moore, Amy P; Ismail-Khan, Roohi; Cox, Charles E; Lacevic, Mensura; Gross-King, Margaret; Xu, Ping; Carter, W Bradford; Minton, Susan E
- Abstract
Chemotherapy-induced amenorrhea is a serious concern for women undergoing cancer therapy. This prospective randomized trial evaluated the use of gonadotropin-releasing hormone (GnRH) analog triptorelin to preserve ovarian function in women treated with chemotherapy for early-stage breast cancer.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Vol 30, Issue 5, p533
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2011.34.6890